Contact, publication, and social network information about Harvard faculty and fellows. Harvard Catalyst Profiles
Keywords
Last Name
Institution

profileSteven James Skates, Ph.D.

TitleAssociate Professor of Medicine
InstitutionMassachusetts General Hospital
DepartmentMedicine
AddressMass General Hospital
Suite 560
50 Staniford Street
Boston MA 02114
Phone617/726-4309
Fax617/724-9878
vCardDownload vCard (login for email)

Collapse Research 
Collapse research activities and funding
The research activities and funding listed below are automatically derived from NIH ExPORTER and other sources, which might result in incorrect or missing items. Faculty can login to make corrections and additions.
U01CA152990     (SKATES, STEVEN J)Sep 24, 2010 - Mar 31, 2021
NIH/NCI
Proteomic, Genomic, and Longitudinal Pathways to Ovarian Cancer Biomarker Discovery
Role: Co-Principal Investigator

P50CA105009     (CRAMER, DANIEL WILLIAM)Aug 1, 2004 - Jul 31, 2012
NIH/NCI
Dana-Farber/Harvard Cancer Center Ovarian Cancer SPORE
Role: Co-Principal Investigator

R03CA073922     (SKATES, STEVEN J)Sep 30, 1997 - Mar 29, 2000
NIH/NCI
OPTIMAL SCREENING FOR PROSTATE CA WITH SERIAL PSA LEVELS
Role: Principal Investigator

R03CA074220     (SKATES, STEVEN J)Jul 18, 1997 - Jun 30, 1999
NIH/NCI
MEASURING AND STATISTICAL MODELING OF SERIAL PSA LEVELS
Role: Principal Investigator

R29CA057693     (SKATES, STEVEN J)Apr 1, 1993 - Mar 31, 1998
NIH/NCI
ONE-STEP OPTIMIZATION OF SCREENING FOR OVARIAN CANCER
Role: Principal Investigator

Collapse Bibliographic 
Collapse selected publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
List All   |   Timeline
  1. Gentry-Maharaj A, Glazer C, Burnell M, Ryan A, Berry H, Kalsi J, Woolas R, Skates SJ, Campbell S, Parmar M, Jacobs I, Menon U. Changing trends in reproductive/lifestyle factors in UK women: descriptive study within the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS). BMJ Open. 2017 Mar 06; 7(3):e011822. PMID: 28264823.
    View in: PubMed
  2. Rosenthal AN, Fraser LS, Philpott S, Manchanda R, Burnell M, Badman P, Hadwin R, Rizzuto I, Benjamin E, Singh N, Evans DG, Eccles DM, Ryan A, Liston R, Dawnay A, Ford J, Gunu R, Mackay J, Skates SJ, Menon U, Jacobs IJ. Evidence of Stage Shift in Women Diagnosed With Ovarian Cancer During Phase II of the United Kingdom Familial Ovarian Cancer Screening Study. J Clin Oncol. 2017 Feb 27; JCO2016699330. PMID: 28240969.
    View in: PubMed
  3. Skates SJ, Greene MH, Buys SS, Mai PL, Brown PH, Piedmonte M, Rodriguez GC, Schorge JO, Sherman M, Daly MB, Rutherford TJ, Brewster WR, O'Malley DM, Partridge EE, Boggess J, Drescher CW, Isaacs C, Berchuck A, Domchek SM, Davidson SA, Edwards RP, Elg SA, Wakeley K, Phillips KA, Armstrong DK, Horowitz IR, Fabian CJ, Walker J, Sluss PM, Welch WR, Minasian L, Horick N, Kasten CH, Nayfield S, Alberts DS, Finkelstein DM, Lu K. Early Detection of Ovarian Cancer using the Risk of Ovarian Cancer Algorithm with Frequent CA125 Testing in Women at Increased Familial Risk - Combined Results from Two Screening Trials. Clin Cancer Res. 2017 Jan 31. PMID: 28143870.
    View in: PubMed
  4. Skates SJ. EPIC Early Detection of Ovarian Cancer. Clin Cancer Res. 2016 Sep 15; 22(18):4542-4. PMID: 27418634; PMCID: PMC5026579 [Available on 03/15/17].
  5. Simmons AR, Clarke CH, Badgwell DB, Lu Z, Sokoll LJ, Lu KH, Zhang Z, Bast RC, Skates SJ. Validation of a Biomarker Panel and Longitudinal Biomarker Performance for Early Detection of Ovarian Cancer. Int J Gynecol Cancer. 2016 Jul; 26(6):1070-7. PMID: 27206285; PMCID: PMC4915986 [Available on 07/01/17].
  6. Jacobs IJ, Parmar M, Skates SJ, Menon U. Ovarian cancer screening: UKCTOCS trial - Authors' reply. Lancet. 2016 Jun 25; 387(10038):2603-4. PMID: 27353822.
    View in: PubMed
  7. Anderson L, Razavi M, Skates S, Anderson NG, Pearson TW. Squeezing more value from the analytes we have: personal baselines for multiple analytes in serial DBS. Bioanalysis. 2016 Aug; 8(15):1539-1542. PMID: 27277878.
    View in: PubMed
  8. Mertins P, Mani DR, Ruggles KV, Gillette MA, Clauser KR, Wang P, Wang X, Qiao JW, Cao S, Petralia F, Kawaler E, Mundt F, Krug K, Tu Z, Lei JT, Gatza ML, Wilkerson M, Perou CM, Yellapantula V, Huang KL, Lin C, McLellan MD, Yan P, Davies SR, Townsend RR, Skates SJ, Wang J, Zhang B, Kinsinger CR, Mesri M, Rodriguez H, Ding L, Paulovich AG, Fenyö D, Ellis MJ, Carr SA. Proteogenomics connects somatic mutations to signalling in breast cancer. Nature. 2016 06 02; 534(7605):55-62. PMID: 27251275.
    View in: PubMed
  9. Russell MR, Walker MJ, Williamson AJ, Gentry-Maharaj A, Ryan A, Kalsi J, Skates S, D'Amato A, Dive C, Pernemalm M, Humphryes PC, Fourkala EO, Whetton AD, Menon U, Jacobs I, Graham RL. Protein Z: A putative novel biomarker for early detection of ovarian cancer. Int J Cancer. 2016 Jun 15; 138(12):2984-92. PMID: 26815306; PMCID: PMC4840324.
  10. Jacobs IJ, Menon U, Ryan A, Gentry-Maharaj A, Burnell M, Kalsi JK, Amso NN, Apostolidou S, Benjamin E, Cruickshank D, Crump DN, Davies SK, Dawnay A, Dobbs S, Fletcher G, Ford J, Godfrey K, Gunu R, Habib M, Hallett R, Herod J, Jenkins H, Karpinskyj C, Leeson S, Lewis SJ, Liston WR, Lopes A, Mould T, Murdoch J, Oram D, Rabideau DJ, Reynolds K, Scott I, Seif MW, Sharma A, Singh N, Taylor J, Warburton F, Widschwendter M, Williamson K, Woolas R, Fallowfield L, McGuire AJ, Campbell S, Parmar M, Skates SJ. Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial. Lancet. 2016 Mar 05; 387(10022):945-56. PMID: 26707054; PMCID: PMC4779792.
  11. Menon U, Kalsi JK, Gentry-Maharaj A, Ryan A, Burnell M, Parmar M, Fallowfield L, Campbell S, McGuire A, Skates S, Jacobs I. Reply to P.F. Pinsky, C.P. Crum, and M.W. McIntosh et al. J Clin Oncol. 2016 Jan 10; 34(2):201-2. PMID: 26573079.
    View in: PubMed
  12. Menon U, Ryan A, Kalsi J, Gentry-Maharaj A, Dawnay A, Habib M, Apostolidou S, Singh N, Benjamin E, Burnell M, Davies S, Sharma A, Gunu R, Godfrey K, Lopes A, Oram D, Herod J, Williamson K, Seif MW, Jenkins H, Mould T, Woolas R, Murdoch JB, Dobbs S, Amso NN, Leeson S, Cruickshank D, Scott I, Fallowfield L, Widschwendter M, Reynolds K, McGuire A, Campbell S, Parmar M, Skates SJ, Jacobs I. Risk Algorithm Using Serial Biomarker Measurements Doubles the Number of Screen-Detected Cancers Compared With a Single-Threshold Rule in the United Kingdom Collaborative Trial of Ovarian Cancer Screening. J Clin Oncol. 2015 Jun 20; 33(18):2062-71. PMID: 25964255; PMCID: PMC4463475 [Available on 06/20/16].
  13. Vathipadiekal V, Wang V, Wei W, Waldron L, Drapkin R, Gillette M, Skates S, Birrer M. Creation of a Human Secretome: A Novel Composite Library of Human Secreted Proteins: Validation Using Ovarian Cancer Gene Expression Data and a Virtual Secretome Array. Clin Cancer Res. 2015 Nov 01; 21(21):4960-9. PMID: 25944803.
    View in: PubMed
  14. Schully SD, Carrick DM, Mechanic LE, Srivastava S, Anderson GL, Baron JA, Berg CD, Cullen J, Diamandis EP, Doria-Rose VP, Goddard KA, Hankinson SE, Kushi LH, Larson EB, McShane LM, Schilsky RL, Shak S, Skates SJ, Urban N, Kramer BS, Khoury MJ, Ransohoff DF. Leveraging biospecimen resources for discovery or validation of markers for early cancer detection. J Natl Cancer Inst. 2015 Apr; 107(4). PMID: 25688116; PMCID: PMC4342676 [Available on 04/01/16].
  15. Menon U, Talaat A, Rosenthal AN, Macdonald ND, Jeyerajah AR, Skates SJ, Sibley K, Oram DH, Jacobs IJ. Performance of ultrasound as a second line test to serum CA125 in ovarian cancer screening. BJOG. 2014 Dec; 121 Suppl 7:35-9. PMID: 25488086.
    View in: PubMed
  16. Creaney J, Segal A, Olsen N, Dick IM, Musk AW, Skates SJ, Robinson BW. Pleural fluid mesothelin as an adjunct to the diagnosis of pleural malignant mesothelioma. Dis Markers. 2014; 2014:413946. PMID: 25505814; PMCID: PMC4258360.
  17. Moore RG, Hawkins DM, Miller MC, Landrum LM, Gajewski W, Ball JJ, Allard WJ, Skates SJ. Combining clinical assessment and the Risk of Ovarian Malignancy Algorithm for the prediction of ovarian cancer. Gynecol Oncol. 2014 Dec; 135(3):547-51. PMID: 25449569.
    View in: PubMed
  18. Sherman ME, Piedmonte M, Mai PL, Ioffe OB, Ronnett BM, Van Le L, Ivanov I, Bell MC, Blank SV, DiSilvestro P, Hamilton CA, Tewari KS, Wakeley K, Kauff ND, Yamada SD, Rodriguez G, Skates SJ, Alberts DS, Walker JL, Minasian L, Lu K, Greene MH. Pathologic findings at risk-reducing salpingo-oophorectomy: primary results from Gynecologic Oncology Group Trial GOG-0199. J Clin Oncol. 2014 Oct 10; 32(29):3275-83. PMID: 25199754; PMCID: PMC4178524.
  19. Creaney J, Dick IM, Meniawy TM, Leong SL, Leon JS, Demelker Y, Segal A, Musk AW, Lee YC, Skates SJ, Nowak AK, Robinson BW. Comparison of fibulin-3 and mesothelin as markers in malignant mesothelioma. Thorax. 2014 Oct; 69(10):895-902. PMID: 25037982; PMCID: PMC4174124.
  20. Skates SJ. A statistical challenge: developing tests for biomarker utility specific to the intended use. J Natl Cancer Inst. 2014 Apr; 106(4):dju076. PMID: 24681600; PMCID: PMC3982897.
  21. Holman LL, Lu KH, Bast RC, Hernandez MA, Bodurka DC, Skates S, Sun CC. Risk perception, worry, and test acceptance in average-risk women who undergo ovarian cancer screening. Am J Obstet Gynecol. 2014 Mar; 210(3):257.e1-6. PMID: 24246524; PMCID: PMC4001707.
  22. Skates SJ, Gillette MA, LaBaer J, Carr SA, Anderson L, Liebler DC, Ransohoff D, Rifai N, Kondratovich M, Težak Ž, Mansfield E, Oberg AL, Wright I, Barnes G, Gail M, Mesri M, Kinsinger CR, Rodriguez H, Boja ES. Statistical design for biospecimen cohort size in proteomics-based biomarker discovery and verification studies. J Proteome Res. 2013 Dec 06; 12(12):5383-94. PMID: 24063748; PMCID: PMC4039197.
  23. Lu KH, Skates S, Hernandez MA, Bedi D, Bevers T, Leeds L, Moore R, Granai C, Harris S, Newland W, Adeyinka O, Geffen J, Deavers MT, Sun CC, Horick N, Fritsche H, Bast RC. A 2-stage ovarian cancer screening strategy using the Risk of Ovarian Cancer Algorithm (ROCA) identifies early-stage incident cancers and demonstrates high positive predictive value. Cancer. 2013 Oct 01; 119(19):3454-61. PMID: 23983047; PMCID: PMC3982191.
  24. Creaney J, Sneddon S, Dick IM, Dare H, Boudville N, Musk AW, Skates SJ, Robinson BW. Comparison of the diagnostic accuracy of the MSLN gene products, mesothelin and megakaryocyte potentiating factor, as biomarkers for mesothelioma in pleural effusions and serum. Dis Markers. 2013; 35(2):119-27. PMID: 24167356; PMCID: PMC3774973.
  25. Abbatiello SE, Mani DR, Schilling B, Maclean B, Zimmerman LJ, Feng X, Cusack MP, Sedransk N, Hall SC, Addona T, Allen S, Dodder NG, Ghosh M, Held JM, Hedrick V, Inerowicz HD, Jackson A, Keshishian H, Kim JW, Lyssand JS, Riley CP, Rudnick P, Sadowski P, Shaddox K, Smith D, Tomazela D, Wahlander A, Waldemarson S, Whitwell CA, You J, Zhang S, Kinsinger CR, Mesri M, Rodriguez H, Borchers CH, Buck C, Fisher SJ, Gibson BW, Liebler D, Maccoss M, Neubert TA, Paulovich A, Regnier F, Skates SJ, Tempst P, Wang M, Carr SA. Design, implementation and multisite evaluation of a system suitability protocol for the quantitative assessment of instrument performance in liquid chromatography-multiple reaction monitoring-MS (LC-MRM-MS). Mol Cell Proteomics. 2013 Sep; 12(9):2623-39. PMID: 23689285; PMCID: PMC3769335.
  26. Rosenthal AN, Fraser L, Manchanda R, Badman P, Philpott S, Mozersky J, Hadwin R, Cafferty FH, Benjamin E, Singh N, Evans DG, Eccles DM, Skates SJ, Mackay J, Menon U, Jacobs IJ. Results of annual screening in phase I of the United Kingdom familial ovarian cancer screening study highlight the need for strict adherence to screening schedule. J Clin Oncol. 2013 Jan 01; 31(1):49-57. PMID: 23213100; PMCID: PMC3530690.
  27. Pinsky PF, Zhu C, Skates SJ, Black A, Partridge E, Buys SS, Berg CD. Potential effect of the risk of ovarian cancer algorithm (ROCA) on the mortality outcome of the Prostate, Lung, Colorectal and Ovarian (PLCO) trial. Int J Cancer. 2013 May 01; 132(9):2127-33. PMID: 23065684.
    View in: PubMed
  28. Menon U, Kalsi J, Jacobs I, Manchanda R, Beller U, Mould T, Skates S, Lokshin A. International Conference on Ovarian Cancer Screening: 29th-30th November 2011, Royal College of Physicians, London. Foreword. Int J Gynecol Cancer. 2012 May; 22 Suppl 1:S1. PMID: 22543910.
    View in: PubMed
  29. Bast RC, Skates S, Lokshin A, Moore RG. Differential diagnosis of a pelvic mass: improved algorithms and novel biomarkers. Int J Gynecol Cancer. 2012 May; 22 Suppl 1:S5-8. PMID: 22543921; PMCID: PMC3389992.
  30. Skates SJ. Ovarian cancer screening: development of the risk of ovarian cancer algorithm (ROCA) and ROCA screening trials. Int J Gynecol Cancer. 2012 May; 22 Suppl 1:S24-6. PMID: 22543916; PMCID: PMC3572791.
  31. Moore RG, Miller MC, Steinhoff MM, Skates SJ, Lu KH, Lambert-Messerlian G, Bast RC. Serum HE4 levels are less frequently elevated than CA125 in women with benign gynecologic disorders. Am J Obstet Gynecol. 2012 Apr; 206(4):351.e1-8. PMID: 22284961; PMCID: PMC3985608.
  32. Kuhn E, Whiteaker JR, Mani DR, Jackson AM, Zhao L, Pope ME, Smith D, Rivera KD, Anderson NL, Skates SJ, Pearson TW, Paulovich AG, Carr SA. Interlaboratory evaluation of automated, multiplexed peptide immunoaffinity enrichment coupled to multiple reaction monitoring mass spectrometry for quantifying proteins in plasma. Mol Cell Proteomics. 2012 Jun; 11(6):M111.013854. PMID: 22199228; PMCID: PMC3433918.
  33. Skates SJ, Mai P, Horick NK, Piedmonte M, Drescher CW, Isaacs C, Armstrong DK, Buys SS, Rodriguez GC, Horowitz IR, Berchuck A, Daly MB, Domchek S, Cohn DE, Van Le L, Schorge JO, Newland W, Davidson SA, Barnes M, Brewster W, Azodi M, Nerenstone S, Kauff ND, Fabian CJ, Sluss PM, Nayfield SG, Kasten CH, Finkelstein DM, Greene MH, Lu K. Large prospective study of ovarian cancer screening in high-risk women: CA125 cut-point defined by menopausal status. Cancer Prev Res (Phila). 2011 Sep; 4(9):1401-8. PMID: 21893500; PMCID: PMC3172691.
  34. Moore RG, Miller MC, Disilvestro P, Landrum LM, Gajewski W, Ball JJ, Skates SJ. Evaluation of the diagnostic accuracy of the risk of ovarian malignancy algorithm in women with a pelvic mass. Obstet Gynecol. 2011 Aug; 118(2 Pt 1):280-8. PMID: 21775843; PMCID: PMC3594110.
  35. Zhang Z, Skates SJ, Sokoll LJ, Lu Z, Clarke CH, Hernandez MA, Lu KH, Bast RC. A multivariate longitudinal algorithm for early detection of ovarian cancer using multiple biomarkers. J Clin Oncol. 2011 May 20; 29(15_suppl):5031. PMID: 28023709.
    View in: PubMed
  36. Creaney J, Yeoman D, Musk AW, de Klerk N, Skates SJ, Robinson BW. Plasma versus serum levels of osteopontin and mesothelin in patients with malignant mesothelioma--which is best? Lung Cancer. 2011 Oct; 74(1):55-60. PMID: 21397972.
    View in: PubMed
  37. Burnell M, Gentry-Maharaj A, Ryan A, Apostolidou S, Habib M, Kalsi J, Skates S, Parmar M, Seif MW, Amso NN, Godfrey K, Oram D, Herod J, Williamson K, Jenkins H, Mould T, Woolas R, Murdoch J, Dobbs S, Leeson S, Cruickshank D, Campbell S, Fallowfield L, Jacobs I, Menon U. Impact on mortality and cancer incidence rates of using random invitation from population registers for recruitment to trials. Trials. 2011 Mar 01; 12:61. PMID: 21362184; PMCID: PMC3058013.
  38. Cramer DW, Bast RC, Berg CD, Diamandis EP, Godwin AK, Hartge P, Lokshin AE, Lu KH, McIntosh MW, Mor G, Patriotis C, Pinsky PF, Thornquist MD, Scholler N, Skates SJ, Sluss PM, Srivastava S, Ward DC, Zhang Z, Zhu CS, Urban N. Ovarian cancer biomarker performance in prostate, lung, colorectal, and ovarian cancer screening trial specimens. Cancer Prev Res (Phila). 2011 Mar; 4(3):365-74. PMID: 21372036; PMCID: PMC3085251.
  39. Zhu CS, Pinsky PF, Cramer DW, Ransohoff DF, Hartge P, Pfeiffer RM, Urban N, Mor G, Bast RC, Moore LE, Lokshin AE, McIntosh MW, Skates SJ, Vitonis A, Zhang Z, Ward DC, Symanowski JT, Lomakin A, Fung ET, Sluss PM, Scholler N, Lu KH, Marrangoni AM, Patriotis C, Srivastava S, Buys SS, Berg CD. A framework for evaluating biomarkers for early detection: validation of biomarker panels for ovarian cancer. Cancer Prev Res (Phila). 2011 Mar; 4(3):375-83. PMID: 21372037; PMCID: PMC3057372.
  40. Jacobs I, Gentry-Maharaj A, Burnell M, Manchanda R, Singh N, Sharma A, Ryan A, Seif MW, Amso NN, Turner G, Brunell C, Fletcher G, Rangar R, Ford K, Godfrey K, Lopes A, Oram D, Herod J, Williamson K, Scott I, Jenkins H, Mould T, Woolas R, Murdoch J, Dobbs S, Leeson S, Cruickshank D, Skates SJ, Fallowfield L, Parmar M, Campbell S, Menon U. Sensitivity of transvaginal ultrasound screening for endometrial cancer in postmenopausal women: a case-control study within the UKCTOCS cohort. Lancet Oncol. 2011 Jan; 12(1):38-48. PMID: 21147030.
    View in: PubMed
  41. Creaney J, Olsen NJ, Brims F, Dick IM, Musk AW, de Klerk NH, Skates SJ, Robinson BW. Serum mesothelin for early detection of asbestos-induced cancer malignant mesothelioma. Cancer Epidemiol Biomarkers Prev. 2010 Sep; 19(9):2238-46. PMID: 20651076.
    View in: PubMed
  42. Moore RG, Jabre-Raughley M, Brown AK, Robison KM, Miller MC, Allard WJ, Kurman RJ, Bast RC, Skates SJ. Comparison of a novel multiple marker assay vs the Risk of Malignancy Index for the prediction of epithelial ovarian cancer in patients with a pelvic mass. Am J Obstet Gynecol. 2010 Sep; 203(3):228.e1-6. PMID: 20471625; PMCID: PMC3594101.
  43. Yurkovetsky Z, Skates S, Lomakin A, Nolen B, Pulsipher T, Modugno F, Marks J, Godwin A, Gorelik E, Jacobs I, Menon U, Lu K, Badgwell D, Bast RC, Lokshin AE. Development of a multimarker assay for early detection of ovarian cancer. J Clin Oncol. 2010 May 01; 28(13):2159-66. PMID: 20368574; PMCID: PMC2860434.
  44. Regnier FE, Skates SJ, Mesri M, Rodriguez H, Tezak Z, Kondratovich MV, Alterman MA, Levin JD, Roscoe D, Reilly E, Callaghan J, Kelm K, Brown D, Philip R, Carr SA, Liebler DC, Fisher SJ, Tempst P, Hiltke T, Kessler LG, Kinsinger CR, Ransohoff DF, Mansfield E, Anderson NL. Protein-based multiplex assays: mock presubmissions to the US Food and Drug Administration. Clin Chem. 2010 Feb; 56(2):165-71. PMID: 20007858.
    View in: PubMed
  45. Rodriguez H, Tezak Z, Mesri M, Carr SA, Liebler DC, Fisher SJ, Tempst P, Hiltke T, Kessler LG, Kinsinger CR, Philip R, Ransohoff DF, Skates SJ, Regnier FE, Anderson NL, Mansfield E. Analytical validation of protein-based multiplex assays: a workshop report by the NCI-FDA interagency oncology task force on molecular diagnostics. Clin Chem. 2010 Feb; 56(2):237-43. PMID: 20007859.
    View in: PubMed
  46. Addona TA, Abbatiello SE, Schilling B, Skates SJ, Mani DR, Bunk DM, Spiegelman CH, Zimmerman LJ, Ham AJ, Keshishian H, Hall SC, Allen S, Blackman RK, Borchers CH, Buck C, Cardasis HL, Cusack MP, Dodder NG, Gibson BW, Held JM, Hiltke T, Jackson A, Johansen EB, Kinsinger CR, Li J, Mesri M, Neubert TA, Niles RK, Pulsipher TC, Ransohoff D, Rodriguez H, Rudnick PA, Smith D, Tabb DL, Tegeler TJ, Variyath AM, Vega-Montoto LJ, Wahlander A, Waldemarson S, Wang M, Whiteaker JR, Zhao L, Anderson NL, Fisher SJ, Liebler DC, Paulovich AG, Regnier FE, Tempst P, Carr SA. Multi-site assessment of the precision and reproducibility of multiple reaction monitoring-based measurements of proteins in plasma. Nat Biotechnol. 2009 Jul; 27(7):633-41. PMID: 19561596; PMCID: PMC2855883.
  47. Manchanda R, Rosenthal A, Burnell M, Fraser L, Mackay J, Skates S. Change in stage distribution observed with annual screening for ovarian cancer in BRCA carriers. J Med Genet. 2009 Jun; 46(6):423-4. PMID: 19487541.
    View in: PubMed
  48. Menon U, Gentry-Maharaj A, Hallett R, Ryan A, Burnell M, Sharma A, Lewis S, Davies S, Philpott S, Lopes A, Godfrey K, Oram D, Herod J, Williamson K, Seif MW, Scott I, Mould T, Woolas R, Murdoch J, Dobbs S, Amso NN, Leeson S, Cruickshank D, McGuire A, Campbell S, Fallowfield L, Singh N, Dawnay A, Skates SJ, Parmar M, Jacobs I. Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS). Lancet Oncol. 2009 Apr; 10(4):327-40. PMID: 19282241.
    View in: PubMed
  49. Menon U, Gentry-Maharaj A, Ryan A, Sharma A, Burnell M, Hallett R, Lewis S, Lopez A, Godfrey K, Oram D, Herod J, Williamson K, Seif M, Scott I, Mould T, Woolas R, Murdoch J, Dobbs S, Amso N, Leeson S, Cruickshank D, McGuire A, Campbell S, Fallowfield L, Skates S, Parmar M, Jacobs I. Recruitment to multicentre trials--lessons from UKCTOCS: descriptive study. BMJ. 2008 Nov 13; 337:a2079. PMID: 19008269; PMCID: PMC2583394.
  50. Moore RG, McMeekin DS, Brown AK, DiSilvestro P, Miller MC, Allard WJ, Gajewski W, Kurman R, Bast RC, Skates SJ. A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass. Gynecol Oncol. 2009 Jan; 112(1):40-6. PMID: 18851871; PMCID: PMC3594094.
  51. Drapkin R, Clauss A, Skates S. Urokinase-type plasminogen activator receptor: a beacon of malignancy? Clin Cancer Res. 2008 Sep 15; 14(18):5643-5. PMID: 18794069; PMCID: PMC2587046.
  52. Creaney J, Yeoman D, Demelker Y, Segal A, Musk AW, Skates SJ, Robinson BW. Comparison of osteopontin, megakaryocyte potentiating factor, and mesothelin proteins as markers in the serum of patients with malignant mesothelioma. J Thorac Oncol. 2008 Aug; 3(8):851-7. PMID: 18670302.
    View in: PubMed
  53. Brown A, Miller C, Robison K, Somers E, Allard J, Granai CO, Skates S, Bast RC, Moore RG. Differential expression of CA125 and a novel serum tumor marker HE4 in epithelial ovarian cancer. J Clin Oncol. 2008 May 20; 26(15_suppl):5533. PMID: 27950487.
    View in: PubMed
  54. Moore RG, Brown AK, Miller MC, Skates S, Allard WJ, Verch T, Steinhoff M, Messerlian G, DiSilvestro P, Granai CO, Bast RC. The use of multiple novel tumor biomarkers for the detection of ovarian carcinoma in patients with a pelvic mass. Gynecol Oncol. 2008 Feb; 108(2):402-8. PMID: 18061248.
    View in: PubMed
  55. Zhang Z, Yu Y, Xu F, Berchuck A, van Haaften-Day C, Havrilesky LJ, de Bruijn HW, van der Zee AG, Woolas RP, Jacobs IJ, Skates S, Chan DW, Bast RC. Combining multiple serum tumor markers improves detection of stage I epithelial ovarian cancer. Gynecol Oncol. 2007 Dec; 107(3):526-31. PMID: 17920110; PMCID: PMC2171045.
  56. Lehman CD, Isaacs C, Schnall MD, Pisano ED, Ascher SM, Weatherall PT, Bluemke DA, Bowen DJ, Marcom PK, Armstrong DK, Domchek SM, Tomlinson G, Skates SJ, Gatsonis C. Cancer yield of mammography, MR, and US in high-risk women: prospective multi-institution breast cancer screening study. Radiology. 2007 Aug; 244(2):381-8. PMID: 17641362.
    View in: PubMed
  57. Creaney J, van Bruggen I, Hof M, Segal A, Musk AW, de Klerk N, Horick N, Skates SJ, Robinson BW. Combined CA125 and mesothelin levels for the diagnosis of malignant mesothelioma. Chest. 2007 Oct; 132(4):1239-46. PMID: 17646232.
    View in: PubMed
  58. Yurkovetsky Z, Ta'asan S, Skates S, Rand A, Lomakin A, Linkov F, Marrangoni A, Velikokhatnaya L, Winans M, Gorelik E, Maxwell GL, Lu K, Lokshin A. Development of multimarker panel for early detection of endometrial cancer. High diagnostic power of prolactin. Gynecol Oncol. 2007 Oct; 107(1):58-65. PMID: 17659325; PMCID: PMC2777971.
  59. Creaney J, Yeoman D, Naumoff LK, Hof M, Segal A, Musk AW, De Klerk N, Horick N, Skates SJ, Robinson BW. Soluble mesothelin in effusions: a useful tool for the diagnosis of malignant mesothelioma. Thorax. 2007 Jul; 62(7):569-76. PMID: 17356060; PMCID: PMC2117248.
  60. Skates SJ, Horick NK, Moy JM, Minihan AM, Seiden MV, Marks JR, Sluss P, Cramer DW. Pooling of case specimens to create standard serum sets for screening cancer biomarkers. Cancer Epidemiol Biomarkers Prev. 2007 Feb; 16(2):334-41. PMID: 17301268.
    View in: PubMed
  61. Bast RC, Brewer M, Zou C, Hernandez MA, Daley M, Ozols R, Lu K, Lu Z, Badgwell D, Mills GB, Skates S, Zhang Z, Chan D, Lokshin A, Yu Y. Prevention and early detection of ovarian cancer: mission impossible? Recent Results Cancer Res. 2007; 174:91-100. PMID: 17302189.
    View in: PubMed
  62. Jacobs IJ, Mackay J, Menon U, Skates SJ, Rosenthal AN, Fraser L. Familial ovarian screening--effective or ineffective? Br J Cancer. 2006 Oct 23; 95(8):1124; author reply 1126-7. PMID: 17047658; PMCID: PMC2360716.
  63. Ye B, Skates S, Mok SC, Horick NK, Rosenberg HF, Vitonis A, Edwards D, Sluss P, Han WK, Berkowitz RS, Cramer DW. Proteomic-based discovery and characterization of glycosylated eosinophil-derived neurotoxin and COOH-terminal osteopontin fragments for ovarian cancer in urine. Clin Cancer Res. 2006 Jan 15; 12(2):432-41. PMID: 16428483.
    View in: PubMed
  64. Baker SG, Kramer BS, McIntosh M, Patterson BH, Shyr Y, Skates S. Evaluating markers for the early detection of cancer: overview of study designs and methods. Clin Trials. 2006; 3(1):43-56. PMID: 16539089.
    View in: PubMed
  65. Bast RC, Badgwell D, Lu Z, Marquez R, Rosen D, Liu J, Baggerly KA, Atkinson EN, Skates S, Zhang Z, Lokshin A, Menon U, Jacobs I, Lu K. New tumor markers: CA125 and beyond. Int J Gynecol Cancer. 2005 Nov-Dec; 15 Suppl 3:274-81. PMID: 16343244.
    View in: PubMed
  66. Menon U, Skates SJ, Lewis S, Rosenthal AN, Rufford B, Sibley K, Macdonald N, Dawnay A, Jeyarajah A, Bast RC, Oram D, Jacobs IJ. Prospective study using the risk of ovarian cancer algorithm to screen for ovarian cancer. J Clin Oncol. 2005 Nov 01; 23(31):7919-26. PMID: 16258091.
    View in: PubMed
  67. Skates SJ, Horick N, Yu Y, Xu FJ, Berchuck A, Havrilesky LJ, de Bruijn HW, van der Zee AG, Woolas RP, Jacobs IJ, Zhang Z, Bast RC. Preoperative sensitivity and specificity for early-stage ovarian cancer when combining cancer antigen CA-125II, CA 15-3, CA 72-4, and macrophage colony-stimulating factor using mixtures of multivariate normal distributions. J Clin Oncol. 2004 Oct 15; 22(20):4059-66. PMID: 15381683.
    View in: PubMed
  68. Skates S, Iliopoulos O. Molecular markers for early detection of renal carcinoma: investigative approach. Clin Cancer Res. 2004 Sep 15; 10(18 Pt 2):6296S-301S. PMID: 15448020.
    View in: PubMed
  69. Isaacs C, Skates SJ, Lehman C, Marcom K, Bowen DJ, Domchek S, Tomlinson G, Armstrong DK, Schnall M. Mammographic, MRI, and ultrasound characteristics of BRCA1, BRCA2, and other genetically high-risk women enrolled in a prospective multi-institution breast cancer screening trial. J Clin Oncol. 2004 Jul 15; 22(14_suppl):9588. PMID: 28016731.
    View in: PubMed
  70. Schorge JO, Drake RD, Lee H, Skates SJ, Rajanbabu R, Miller DS, Kim JH, Cramer DW, Berkowitz RS, Mok SC. Osteopontin as an adjunct to CA125 in detecting recurrent ovarian cancer. Clin Cancer Res. 2004 May 15; 10(10):3474-8. PMID: 15161704.
    View in: PubMed
  71. Penson RT, Oliva E, Skates SJ, Glyptis T, Fuller AF, Goodman A, Seiden MV. Expression of multidrug resistance-1 protein inversely correlates with paclitaxel response and survival in ovarian cancer patients: a study in serial samples. Gynecol Oncol. 2004 Apr; 93(1):98-106. PMID: 15047220.
    View in: PubMed
  72. Terry KL, Sluss PM, Skates SJ, Mok SC, Ye B, Vitonis AF, Cramer DW. Blood and urine markers for ovarian cancer: a comprehensive review. Dis Markers. 2004; 20(2):53-70. PMID: 15322314; PMCID: PMC3839278.
  73. Kim JH, Herlyn D, Wong KK, Park DC, Schorge JO, Lu KH, Skates SJ, Cramer DW, Berkowitz RS, Mok SC. Identification of epithelial cell adhesion molecule autoantibody in patients with ovarian cancer. Clin Cancer Res. 2003 Oct 15; 9(13):4782-91. PMID: 14581349.
    View in: PubMed
  74. Skates S, Troiano R, Knapp RC. Longitudinal CA125 detection of sporadic papillary serous carcinoma of the peritoneum. Int J Gynecol Cancer. 2003 Sep-Oct; 13(5):693-6. PMID: 14675358.
    View in: PubMed
  75. Ye B, Cramer DW, Skates SJ, Gygi SP, Pratomo V, Fu L, Horick NK, Licklider LJ, Schorge JO, Berkowitz RS, Mok SC. Haptoglobin-alpha subunit as potential serum biomarker in ovarian cancer: identification and characterization using proteomic profiling and mass spectrometry. Clin Cancer Res. 2003 Aug 01; 9(8):2904-11. PMID: 12912935.
    View in: PubMed
  76. Skates SJ, Menon U, MacDonald N, Rosenthal AN, Oram DH, Knapp RC, Jacobs IJ. Calculation of the risk of ovarian cancer from serial CA-125 values for preclinical detection in postmenopausal women. J Clin Oncol. 2003 May 15; 21(10 Suppl):206s-210s. PMID: 12743136.
    View in: PubMed
  77. Cannistra SA, Bast RC, Berek JS, Bookman MA, Crum CP, DePriest PD, Garber JE, Koh WJ, Markman M, McGuire WP, Rose PG, Rowinsky EK, Rustin GJ, Skates SJ, Vasey PA, King L. Progress in the management of gynecologic cancer: consensus summary statement. J Clin Oncol. 2003 May 15; 21(10 Suppl):129s-132s. PMID: 12743127.
    View in: PubMed
  78. Kim JH, Skates SJ, Uede T, Wong KK, Schorge JO, Feltmate CM, Berkowitz RS, Cramer DW, Mok SC. Osteopontin as a potential diagnostic biomarker for ovarian cancer. JAMA. 2002 Apr 03; 287(13):1671-9. PMID: 11926891.
    View in: PubMed
  79. Skates SJ. Screening for ovarian cancer-risk, education, worry: path to appropriate use? Gynecol Oncol. 2002 Apr; 85(1):1-2. PMID: 11925112.
    View in: PubMed
  80. Parmigiani G, Skates S, Zelen M. Modeling and optimization in early detection programs with a single exam. Biometrics. 2002 Mar; 58(1):30-6. PMID: 11890325.
    View in: PubMed
  81. Bast RC, Urban N, Shridhar V, Smith D, Zhang Z, Skates S, Lu K, Liu J, Fishman D, Mills G. Early detection of ovarian cancer: promise and reality. Cancer Treat Res. 2002; 107:61-97. PMID: 11775462.
    View in: PubMed
  82. Mok SC, Chao J, Skates S, Wong K, Yiu GK, Muto MG, Berkowitz RS, Cramer DW. Prostasin, a potential serum marker for ovarian cancer: identification through microarray technology. J Natl Cancer Inst. 2001 Oct 03; 93(19):1458-64. PMID: 11584061.
    View in: PubMed
  83. Zweemer RP, Verheijen RH, Coebergh JW, Jacobs IJ, van Diest PJ, Gille JJ, Skates S, Menko FH, Ten Kate LP, Kenemans P. Survival analysis in familial ovarian cancer, a case control study. Eur J Obstet Gynecol Reprod Biol. 2001 Oct; 98(2):219-23. PMID: 11574135.
    View in: PubMed
  84. Hylek EM, Regan S, Go AS, Hughes RA, Singer DE, Skates SJ. Clinical predictors of prolonged delay in return of the international normalized ratio to within the therapeutic range after excessive anticoagulation with warfarin. Ann Intern Med. 2001 Sep 18; 135(6):393-400. PMID: 11560452.
    View in: PubMed
  85. Pauler DK, Menon U, McIntosh M, Symecko HL, Skates SJ, Jacobs IJ. Factors influencing serum CA125II levels in healthy postmenopausal women. Cancer Epidemiol Biomarkers Prev. 2001 May; 10(5):489-93. PMID: 11352859.
    View in: PubMed
  86. Skates SJ, Jacobs IJ, Knapp RC. Tumor markers in screening for ovarian cancer. Methods Mol Med. 2001; 39:61-73. PMID: 21340758.
    View in: PubMed
  87. Hylek EM, Chang YC, Skates SJ, Hughes RA, Singer DE. Prospective study of the outcomes of ambulatory patients with excessive warfarin anticoagulation. Arch Intern Med. 2000 Jun 12; 160(11):1612-7. PMID: 10847254.
    View in: PubMed
  88. Menon U, Talaat A, Rosenthal AN, Macdonald ND, Jeyerajah AR, Skates SJ, Sibley K, Oram DH, Jacobs IJ. Performance of ultrasound as a second line test to serum CA125 in ovarian cancer screening. BJOG. 2000 Feb; 107(2):165-9. PMID: 10688498.
    View in: PubMed
  89. Jacobs I, Skates S, Macdonald N. Ovarian cancer screening was feasible but did not decrease incidence of index cancer or mortality. West J Med. 2000 Feb; 172(2):97. PMID: 18751238.
    View in: PubMed
  90. Penson RT, Skates SJ, Fuller AJ, Seiden MV. Clinical course of stage IV epithelial ovarian cancer. J Clin Oncol. 1999 Oct; 17(10):3361-2. PMID: 10506641.
    View in: PubMed
  91. Menon U, Talaat A, Jeyarajah AR, Rosenthal AN, MacDonald ND, Skates SJ, Sibley K, Oram DH, Jacobs IJ. Ultrasound assessment of ovarian cancer risk in postmenopausal women with CA125 elevation. Br J Cancer. 1999 Jul; 80(10):1644-7. PMID: 10408412; PMCID: PMC2363093.
  92. Jeyarajah AR, Ind TE, MacDonald N, Skates S, Oram DH, Jacobs IJ. Increased mortality in postmenopausal women with serum CA125 elevation. Gynecol Oncol. 1999 May; 73(2):242-6. PMID: 10329041.
    View in: PubMed
  93. Jeyarajah AR, Ind TE, Skates S, Oram DH, Jacobs IJ. Serum CA125 elevation and risk of clinical detection of cancer in asymptomatic postmenopausal women. Cancer. 1999 May 01; 85(9):2068-72. PMID: 10223249.
    View in: PubMed
  94. Jacobs IJ, Skates SJ, MacDonald N, Menon U, Rosenthal AN, Davies AP, Woolas R, Jeyarajah AR, Sibley K, Lowe DG, Oram DH. Screening for ovarian cancer: a pilot randomised controlled trial. Lancet. 1999 Apr 10; 353(9160):1207-10. PMID: 10217079.
    View in: PubMed
  95. Eliason BC, Larson W, Singer DE, Skates SJ. Acetaminophen and risk factors for excess anticoagulation with warfarin. JAMA. 1998 Aug 26; 280(8):696-7. PMID: 9728633.
    View in: PubMed
  96. Lein M, Koenig F, Jung K, McGovern FJ, Skates SJ, Schnorr D, Loening SA. The percentage of free prostate specific antigen is an age-independent tumour marker for prostate cancer: establishment of reference ranges in a large population of healthy men. Br J Urol. 1998 Aug; 82(2):231-6. PMID: 9722758.
    View in: PubMed
  97. Hylek EM, Heiman H, Skates SJ, Sheehan MA, Singer DE. Acetaminophen and other risk factors for excessive warfarin anticoagulation. JAMA. 1998 Mar 04; 279(9):657-62. PMID: 9496982.
    View in: PubMed
  98. Merkel PA, Polisson RP, Chang Y, Skates SJ, Niles JL. Prevalence of antineutrophil cytoplasmic antibodies in a large inception cohort of patients with connective tissue disease. Ann Intern Med. 1997 Jun 01; 126(11):866-73. PMID: 9163287.
    View in: PubMed
  99. Jacobs IJ, Skates S, Davies AP, Woolas RP, Jeyerajah A, Weidemann P, Sibley K, Oram DH. Risk of diagnosis of ovarian cancer after raised serum CA 125 concentration: a prospective cohort study. BMJ. 1996 Nov 30; 313(7069):1355-8. PMID: 8956699; PMCID: PMC2352927.
  100. Hylek EM, Skates SJ, Sheehan MA, Singer DE. An analysis of the lowest effective intensity of prophylactic anticoagulation for patients with nonrheumatic atrial fibrillation. N Engl J Med. 1996 Aug 22; 335(8):540-6. PMID: 8678931.
    View in: PubMed
  101. Skates SJ, Xu FJ, Yu YH, Sjövall K, Einhorn N, Chang Y, Bast RC, Knapp RC. Toward an optimal algorithm for ovarian cancer screening with longitudinal tumor markers. Cancer. 1995 Nov 15; 76(10 Suppl):2004-10. PMID: 8634992.
    View in: PubMed
  102. Carlson KJ, Skates SJ, Singer DE. Screening for ovarian cancer. Ann Intern Med. 1994 Jul 15; 121(2):124-32. PMID: 8017726.
    View in: PubMed
  103. Atlas SJ, Singer DE, Skates SJ. Changing blood use in the AIDS era: the case of elective hip surgery. Transfusion. 1994 May; 34(5):386-91. PMID: 8191561.
    View in: PubMed
  104. Maciejewski BA, Skates S, Zajusz A, Lange D. Importance of tumor size and repopulation for radiocurability of skin cancer. Neoplasma. 1993; 40(1):51-4. PMID: 8350948.
    View in: PubMed
  105. Suit H, Skates S, Taghian A, Okunieff P, Efird JT. Clinical implications of heterogeneity of tumor response to radiation therapy. Radiother Oncol. 1992 Dec; 25(4):251-60. PMID: 1480770.
    View in: PubMed
  106. Urie MM, Fullerton B, Tatsuzaki H, Birnbaum S, Suit HD, Convery K, Skates S, Goitein M. A dose response analysis of injury to cranial nerves and/or nuclei following proton beam radiation therapy. Int J Radiat Oncol Biol Phys. 1992; 23(1):27-39. PMID: 1572828.
    View in: PubMed
  107. Eagle KA, Mulley AG, Field TS, Skates S, Bero G, Clark CE, Sexton JO, Reder VA, Berrigan G, Procaccini J, et al. Variation in intensive care unit practices in two community hospitals. Med Care. 1991 Dec; 29(12):1237-45. PMID: 1745081.
    View in: PubMed
  108. Niles JL, Pan GL, Collins AB, Shannon T, Skates S, Fienberg R, Arnaout MA, McCluskey RT. Antigen-specific radioimmunoassays for anti-neutrophil cytoplasmic antibodies in the diagnosis of rapidly progressive glomerulonephritis. J Am Soc Nephrol. 1991 Jul; 2(1):27-36. PMID: 1655091.
    View in: PubMed
  109. Rigotti NA, Neer RM, Skates SJ, Herzog DB, Nussbaum SR. The clinical course of osteoporosis in anorexia nervosa. A longitudinal study of cortical bone mass. JAMA. 1991 Mar 06; 265(9):1133-8. PMID: 1995999.
    View in: PubMed
  110. Skates SJ, Singer DE. Quantifying the potential benefit of CA 125 screening for ovarian cancer. J Clin Epidemiol. 1991; 44(4-5):365-80. PMID: 2010780.
    View in: PubMed
  111. Eagle KA, Mulley AG, Skates SJ, Reder VA, Nicholson BW, Sexton JO, Barnett GO, Thibault GE. Length of stay in the intensive care unit. Effects of practice guidelines and feedback. JAMA. 1990 Aug 22-29; 264(8):992-7. PMID: 2376892.
    View in: PubMed
  112. Thor AD, Schwartz LH, Koerner FC, Edgerton SM, Skates SJ, Yin S, McKenzie SJ, Panicali DL, Marks PJ, Fingert HJ, et al. Analysis of c-erbB-2 expression in breast carcinomas with clinical follow-up. Cancer Res. 1989 Dec 15; 49(24 Pt 1):7147-52. PMID: 2573426.
    View in: PubMed
  113. Suit HD, Baumann M, Skates S, Convery K. Clinical interest in determinations of cellular radiation sensitivity. Int J Radiat Biol. 1989 Nov; 56(5):725-37. PMID: 2573670.
    View in: PubMed
  114. Lauk S, Skates S, Goodman M, Suit HD. A morphometric study of the vascularity of oral squamous cell carcinomas and its relation to outcome of radiation therapy. Eur J Cancer Clin Oncol. 1989 Oct; 25(10):1431-40. PMID: 2591435.
    View in: PubMed
  115. Tolentino FI, Cajita VN, Gancayco T, Skates S. Vitreous hemorrhage after closed vitrectomy for proliferative diabetic retinopathy. Ophthalmology. 1989 Oct; 96(10):1495-500. PMID: 2587044.
    View in: PubMed
  116. Lauk S, Zietman A, Skates S, Fabian R, Suit HD. Comparative morphometric study of tumor vasculature in human squamous cell carcinomas and their xenotransplants in athymic nude mice. Cancer Res. 1989 Aug 15; 49(16):4557-61. PMID: 2743340.
    View in: PubMed
  117. Austin-Seymour M, Munzenrider J, Goitein M, Verhey L, Urie M, Gentry R, Birnbaum S, Ruotolo D, McManus P, Skates S, et al. Fractionated proton radiation therapy of chordoma and low-grade chondrosarcoma of the base of the skull. J Neurosurg. 1989 Jan; 70(1):13-7. PMID: 2535872.
    View in: PubMed
  118. Okunieff P, Rummeny E, Vaupel P, Skates S, Willett C, Neuringer LJ, Suit HD. Effects of pentobarbital anesthesia on the energy metabolism of murine tumors studied by in vivo 31P nuclear magnetic resonance spectroscopy. Radiat Res. 1988 Aug; 115(2):361-72. PMID: 3406373.
    View in: PubMed
  119. Willett CG, Stracher MA, Linggood RM, Miketic LM, Leong JC, Skates SJ, Kushner DC, Jacobson JO. Three-dimensional volumetric assessment of response to treatment: stage I and II diffuse large cell lymphoma of the mediastinum. Radiother Oncol. 1988 Jul; 12(3):193-8. PMID: 3175046.
    View in: PubMed
  120. Willett CG, Linggood RM, Leong JC, Miketic LM, Stracher MA, Skates SJ, Kushner DC. Stage IA to IIB mediastinal Hodgkin's disease: three-dimensional volumetric assessment of response to treatment. J Clin Oncol. 1988 May; 6(5):819-24. PMID: 3367187.
    View in: PubMed
  121. Willett CG, Tepper JE, Skates SJ, Wood WC, Orlow EC, Duttenhaver JR. Adjuvant postoperative radiation therapy for colonic carcinoma. Ann Surg. 1987 Dec; 206(6):694-8. PMID: 3689006; PMCID: PMC1493317.
  122. Keast D, Rowe P, Sanfelieu L, Shannahan J, Bowra B, Skates S, Stapley EO, Woodruff HB. Use of a computer to group actinomycetes for studies on the ecology of soil microorganisms. Appl Environ Microbiol. 1984 Oct; 48(4):791-6. PMID: 6508288; PMCID: PMC241615.
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For demographic and contact information changes only, HMS/HSDM faculty should contact Human Resources at human_resourceshms.harvard.edu.
Skates's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_